查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1602383

主动式植入式医疗设备市场：按产品类型、植入类型和最终用户划分 - 2025-2030 年全球预测

Active Implantable Medical Devices Market by Product (Cochlear Implants, Haemodynamic Support, Implantable Cardiac Pacemakers), Implant Type (Complete implantable, Partial implantable), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

有源植入式医疗设备市场2023年估值为26.5亿美元，预计2024年将达29.1亿美元，复合年增长率为9.92%，2030年将达51.4亿美元。

主动植入式医疗设备(AIMD) 是透过手术或医学方式永久植入人体并在治疗严重医疗状况后保留在体内的装置。包括心律调节器、心臟去颤器、神经刺激设备和人工电子耳等设备。这些设备对于缓解症状和恢復身体功能对于慢性病患者至关重要。心血管疾病、神经系统疾病和听力障碍盛行率的增加是市场需求的主要驱动力。此外，医疗保健支出的增加、医疗技术的进步和人口老化也对市场扩张做出了重大贡献。目前的技术创新，例如小型化、无线技术和改进的生物相容性，提供了充满希望的机会。鼓励公司投资研发，专注于开发可延长电池寿命并降低感染风险的多功能设备。儘管前景乐观，但严格的监管要求、高昂的开拓成本以及设备故障引起的併发症等挑战正在限制市场成长。为了缓解这些障碍，必须认真对待合规和风险管理框架。此外，各国复杂的报销制度也加剧了市场紧张。然而，整合远端医疗整合和远端监控功能等数位健康应用程式可以为您的业务带来显着的效益。此外，探索个人化医疗也具有潜力，即根据基因图谱和特定患者需求客製化设备。由于医疗基础设施不发达和患者群庞大，新兴市场提供了开拓的商机。您还可以透过与医疗保健提供者建立策略伙伴关係关係并专注于 AIMD 的教育倡议来提高市场渗透率。简而言之，透过创新、适应性和策略伙伴关係关係的正确结合，AIMD 市场的成长时机已经成熟，但必须谨慎应对监管和财务限制。

主要市场统计
基准年[2023] 26.5亿美元
预测年份 [2024] 29.1亿美元
预测年份 [2030] 51.4亿美元
复合年增长率（%） 9.92%

市场动态：快速发展的主动植入医疗设备市场的关键市场洞察

有源植入式医疗设备市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 心血管疾病盛行率上升
    • 神经系统疾病患者增加
    • 提高神经刺激设备的认识与传播
  • 市场限制因素
    • 与植入式医疗设备相关的不良健康影响
  • 市场机会
    • 下一代IMD中运算和通讯功能的集成
    • 先进医疗设备领域研发投入快速增加
  • 市场挑战
    • 对高成本和严格的许可规定的担忧

波特五力：驾驭主动植入医疗设备市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解有源植入医疗设备市场的外部影响

外部宏观环境因素在塑造主动植入医疗设备市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解主动式植入医疗设备市场的竞争格局

有源植入式医疗设备市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来发现自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵主动式植入医疗设备市场供应商的绩效评估

FPNV 定位矩阵是评估主动式植入医疗设备市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，为主动植入式医疗设备市场的成功指明道路

对于旨在加强其在全球市场的影响力的公司来说，有源植入式医疗设备市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 心血管疾病盛行率上升
      • 神经系统疾病患者增加
      • 提高神经刺激设备的认识与采用
    • 抑制因素
      • 植入式医疗设备对健康的不良影响
    • 机会
      • 下一代IMD中运算和通讯功能的集成
      • 先进医疗设备领域研发投入快速增加
    • 任务
      • 对高成本和严格许可规定的担忧
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章主动置入医疗设备市场：依产品

  • 人工电子耳
  • 血流动力学支持
  • 植入式心臟心律调节器
  • 植入式心臟整流去颤器
  • 植入式血糖监测仪
  • 植入式输液帮浦及配件
  • 植入式监测装置
  • 植入式神经刺激系统
  • 辅助人工心臟

第 7 章依植入类型分類的主动植入医疗设备市场

  • 完整植入
  • 部分嵌入型

第八章活跃的植入式医疗设备市场：依最终用户分类

  • 门诊中心
  • 心臟中心
  • 牙医诊所
  • 医院

第九章美洲活跃的植入式医疗设备市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太有源植入医疗设备市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲活跃的植入式医疗设备市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • 3M Company
  • Abbott Laboratories
  • Aleva Neurotherapeutics
  • Allergan Inc. by AbbVie Inc.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • CONMED Corporation
  • Definitive Healthcare, LLC
  • Demant A/S
  • Dentsply Sirona Inc.
  • Globus Medical, Inc.
  • GMED
  • Integra Lifesciences Holdings Corporation
  • Invibio Ltd.
  • Johnson & Johnson Services, Inc.
  • LivaNova PLC
  • Medtronic PLC
  • Microport Scientific Corporation
  • NuVasive, Inc.
  • Smith & Nephew PLC
  • Sonova Holding AG
  • Straumann AG
  • Stryker Corporation
  • TUV Rheinland AG
  • Zhejiang Nuoerkang Neuroelectronic Technology Co., Ltd.
  • Zimmer Biomet
Product Code: MRR-4369010661A4

The Active Implantable Medical Devices Market was valued at USD 2.65 billion in 2023, expected to reach USD 2.91 billion in 2024, and is projected to grow at a CAGR of 9.92%, to USD 5.14 billion by 2030.

Active Implantable Medical Devices (AIMDs) refer to instruments intended to be introduced fully, surgically, or medically into the human body, and stay there post-procedure, to manage severe medical conditions. They encompass devices like pacemakers, defibrillators, neurostimulators, and cochlear implants. These devices are crucial for patients with chronic conditions by alleviating symptoms or restoring bodily functions. The growing prevalence of cardiovascular diseases, neurological disorders, and hearing impairments are key drivers of market demand. Additionally, increasing healthcare spending, advancements in medical technologies, and aging populations contribute significantly to market expansion. Current innovations, such as miniaturization, wireless technologies, and improved biocompatibility, present promising opportunities. Companies are encouraged to invest in R&D, focusing on creating multifunctional devices with enhanced battery life and reduced risk of infection. Despite the optimism, challenges such as stringent regulatory requirements, high costs of development, and complications arising from device failure limit market growth. The necessity for diligent compliance and risk management frameworks is crucial to mitigate such hindrances. The complex reimbursement landscapes in different countries further add to market strain. However, embracing digital health applications, such as telemedicine integration and remote monitoring capabilities, can provide significant business advantages. Furthermore, there is potential in exploring personalized medicine to customize devices based on genetic profiles and specific patient needs. Emerging markets present untapped opportunities due to inadequate healthcare infrastructure and the availability of a large patient pool. Engaging in strategic partnerships with healthcare providers and focusing on educational initiatives about AIMDs can also boost market penetration. In essence, the AIMD market is ripe for growth with the right blend of innovation, adaptability, and strategic partnerships, although careful navigation of regulatory and financial constraints is necessary.

KEY MARKET STATISTICS
Base Year [2023] USD 2.65 billion
Estimated Year [2024] USD 2.91 billion
Forecast Year [2030] USD 5.14 billion
CAGR (%) 9.92%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Active Implantable Medical Devices Market

The Active Implantable Medical Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of cardiovascular diseases
    • Growing number of patients with neurological disorders
    • Increase in awareness and adoption of neurostimulator devices
  • Market Restraints
    • Associated adverse health impacts of implantable medical devices
  • Market Opportunities
    • Integration of computing and communication capabilities in next generation IMDs
    • Surging R&D investment in field of advanced medical devices
  • Market Challenges
    • Concern regarding high cost and stringent regulations for approval

Porter's Five Forces: A Strategic Tool for Navigating the Active Implantable Medical Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Active Implantable Medical Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Active Implantable Medical Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Active Implantable Medical Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Active Implantable Medical Devices Market

A detailed market share analysis in the Active Implantable Medical Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Active Implantable Medical Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Active Implantable Medical Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Active Implantable Medical Devices Market

A strategic analysis of the Active Implantable Medical Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Active Implantable Medical Devices Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Aleva Neurotherapeutics, Allergan Inc. by AbbVie Inc., BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Cochlear Ltd., CONMED Corporation, Definitive Healthcare, LLC, Demant A/S, Dentsply Sirona Inc., Globus Medical, Inc., GMED, Integra Lifesciences Holdings Corporation, Invibio Ltd., Johnson & Johnson Services, Inc., LivaNova PLC, Medtronic PLC, Microport Scientific Corporation, NuVasive, Inc., Smith & Nephew PLC, Sonova Holding AG, Straumann AG, Stryker Corporation, TUV Rheinland AG, Zhejiang Nuoerkang Neuroelectronic Technology Co., Ltd., and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Active Implantable Medical Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Cochlear Implants, Haemodynamic Support, Implantable Cardiac Pacemakers, Implantable Defibrillators, Implantable Glucose Monitors, Implantable Infusion Pumps & Accessories, Implantable Monitoring Devices, Implantable Neuro Stimulator Systems, and Ventricular Assist Devices.
  • Based on Implant Type, market is studied across Complete implantable and Partial implantable.
  • Based on End-User, market is studied across Ambulatory Centers, Cardiac Centers, Dental Clinics, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of cardiovascular diseases
      • 5.1.1.2. Growing number of patients with neurological disorders
      • 5.1.1.3. Increase in awareness and adoption of neurostimulator devices
    • 5.1.2. Restraints
      • 5.1.2.1. Associated adverse health impacts of implantable medical devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of computing and communication capabilities in next generation IMDs
      • 5.1.3.2. Surging R&D investment in field of advanced medical devices
    • 5.1.4. Challenges
      • 5.1.4.1. Concern regarding high cost and stringent regulations for approval
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Active Implantable Medical Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Cochlear Implants
  • 6.3. Haemodynamic Support
  • 6.4. Implantable Cardiac Pacemakers
  • 6.5. Implantable Defibrillators
  • 6.6. Implantable Glucose Monitors
  • 6.7. Implantable Infusion Pumps & Accessories
  • 6.8. Implantable Monitoring Devices
  • 6.9. Implantable Neuro Stimulator Systems
  • 6.10. Ventricular Assist Devices

7. Active Implantable Medical Devices Market, by Implant Type

  • 7.1. Introduction
  • 7.2. Complete implantable
  • 7.3. Partial implantable

8. Active Implantable Medical Devices Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Centers
  • 8.3. Cardiac Centers
  • 8.4. Dental Clinics
  • 8.5. Hospitals

9. Americas Active Implantable Medical Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Active Implantable Medical Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Active Implantable Medical Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Abbott Laboratories
  • 3. Aleva Neurotherapeutics
  • 4. Allergan Inc. by AbbVie Inc.
  • 5. BIOTRONIK SE & Co. KG
  • 6. Boston Scientific Corporation
  • 7. Cochlear Ltd.
  • 8. CONMED Corporation
  • 9. Definitive Healthcare, LLC
  • 10. Demant A/S
  • 11. Dentsply Sirona Inc.
  • 12. Globus Medical, Inc.
  • 13. GMED
  • 14. Integra Lifesciences Holdings Corporation
  • 15. Invibio Ltd.
  • 16. Johnson & Johnson Services, Inc.
  • 17. LivaNova PLC
  • 18. Medtronic PLC
  • 19. Microport Scientific Corporation
  • 20. NuVasive, Inc.
  • 21. Smith & Nephew PLC
  • 22. Sonova Holding AG
  • 23. Straumann AG
  • 24. Stryker Corporation
  • 25. TUV Rheinland AG
  • 26. Zhejiang Nuoerkang Neuroelectronic Technology Co., Ltd.
  • 27. Zimmer Biomet

LIST OF FIGURES

  • FIGURE 1. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COCHLEAR IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HAEMODYNAMIC SUPPORT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANTABLE CARDIAC PACEMAKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANTABLE DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANTABLE GLUCOSE MONITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANTABLE INFUSION PUMPS & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANTABLE MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANTABLE NEURO STIMULATOR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COMPLETE IMPLANTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PARTIAL IMPLANTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. MALAYSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. PHILIPPINES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. SINGAPORE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. SOUTH KOREA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. TAIWAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. THAILAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. VIETNAM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. DENMARK ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. EGYPT ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. FINLAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. ISRAEL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. ITALY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NETHERLANDS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. NIGERIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. NORWAY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. POLAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. QATAR ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. RUSSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SAUDI ARABIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SPAIN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. SWEDEN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. SWITZERLAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. TURKEY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED ARAB EMIRATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 153. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2023